Company
InMed Pharmaceuticals Inc. (INM)
Standardized SEC financial data for InMed Pharmaceuticals Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001728328 · NASDAQ · Pharmaceutical Preparations.
Gross margin
34.5%
Operating margin
-160.8%
Net margin
-165.1%
Revenue growth (YoY)
7.5%
Return on equity
-60.8%
Free cash flow
-$7.8M
Current ratio
6.99×
EPS (diluted)
$-8.36
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | $1.9M | $1.4M | $4.1M | $4.6M | $4.9M |
| Cost of revenue |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.8M | $7.4M | $6.2M | $8.9M | $6.6M | $11.1M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$7.4M | -$9.8M | -$15.6M | -$7.3M | -$7.0M | -$7.8M |
| Capital expenditures |
Get INM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/INM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/INM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"